Kidney stones are a common and serious health threat. In Taiwan, one in every ten individuals suffers from this condition. Despite advances in treatment, the high recurrence rate and potential complications, such as septic shock or kidney failure, continue to pose significant challenges. Current diagnostic methods, including X-rays and ultrasound, offer some support but are limited in accuracy and require interpretation by skilled physicians. The results often vary depending on the doctor's expertise, and imaging tests can expose patients to radiation risks.

To address these issues, the research team at Kaohsiung Municipal Ta-Tung Hospital has developed an innovative solution: the "Rapid Kidney Stone AI Screening System." Utilizing advanced artificial intelligence (AI) technology, this system can quickly and accurately assess a patient’s risk of kidney stones based on simple blood and urine test data.

AI-Powered, Efficient, and Cost-Effective Kidney Stone Screening

The core of this system lies in deep learning and model training based on 6,000 clinical data samples. The AI model can rapidly analyze data to predict kidney stone risk. Compared to traditional diagnostic methods, this system offers several advantages. It eliminates the need for imaging, relying solely on blood and urine test data, thus reducing medical costs and avoiding radiation exposure from X-rays. Additionally, while the diagnostic accuracy of traditional X-ray and ultrasound methods is about 70%, this AI system achieves an accuracy rate of 91.7%, enabling early detection before symptoms even appear.

The system’s convenience is another key feature. Users can input clinical information via personal computers, smartphones, or tablets. The server collects this data and connects to the AI model through an API. After processing, the system provides a rapid risk assessment for kidney stones. The process is simple, quick, and completely non-invasive, sparing patients from the discomfort and complexity of traditional diagnostic procedures. This reduces the psychological burden of screening and encourages more people to identify potential health risks early, allowing for timely treatment and reducing the dangers of delayed diagnosis.

Dr. Hao-Wei Chen on AI Applications in Kidney Stone Screening and Future Prospects

Dr. Hao-Wei Chen emphasized that the development of this AI screening system aims to overcome the challenges in current kidney stone diagnostics. Traditional imaging methods often yield inconsistent results and are heavily influenced by a physician’s experience. In contrast, the AI system, trained on extensive clinical data, eliminates these variables and delivers stable, accurate screening results.

Dr. Chen highlighted that the technology not only facilitates early detection of kidney stones before symptoms appear but also aids in identifying high-risk groups, such as individuals with a family history of kidney stones, obesity, or those working in high-temperature environments. By enabling preventive screening, the system offers significant public health benefits.

The team is committed to bringing this groundbreaking technology to the global market. Efforts are underway to conduct further clinical validation and regulatory approval processes, with the ultimate goal of integrating this innovation into formal medical device management systems.

Resource: 手機輸資訊連結AI 速判腎結石風險